Journal of Ophthalmic and Vision Research
ISSN: 2008-322X
The latest research in clinical ophthalmology and vision science
Conjunctivitis: A Systematic Review
Published date: Jul 29 2020
Journal Title: Journal of Ophthalmic and Vision Research
Issue title: July–September 2020, Volume 15, Issue 3
Pages: 372 - 395
Authors:
Abstract:
Conjunctivitis is a commonly encountered condition in ophthalmology clinics throughout the world. In the management of suspected cases of conjunctivitis, alarming signs for more serious intraocular conditions, such as severe pain, decreased vision, and painful pupillary reaction, must be considered. Additionally, a thorough medical and ophthalmic history should be obtained and a thorough physical examination should be done in patients with atypical findings and chronic course. Concurrent physical exam findings with relevant history may reveal the presence of a systemic condition with involvement of the conjunctiva. Viral conjunctivitis remains to be the most common overall cause of conjunctivitis. Bacterial conjunctivitis is encountered less frequently and it is the second most common cause of infectious conjunctivitis. Allergic conjunctivitis is encountered in nearly half of the population and the findings include itching, mucoid discharge, chemosis, and eyelid edema. Long-term usage of eye drops with preservatives in a patient with conjunctival irritation and discharge points to the toxic conjunctivitis as the underlying etiology. Effective management of conjunctivitis includes timely diagnosis, appropriate differentiation of the various etiologies, and appropriate treatment.
Keywords: Allergic, Bacterial, Conjunctivitis, COVID-19, Coronavirus, Viral, Toxic
References:
1. Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology 2017;124:1099–1107.
2. Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol 2009;9:13.
3. Ryder EC, Benson S. Conjunctivitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2020.
4. de Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L, et al. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis 2013;8:8–8.
5. Sati A, Sangwan VS, Basu S. Porphyria: varied ocular manifestations and management. BMJ Case Rep 2013;2013:bcr2013009496.
6. Narayana S, McGee S. Bedside diagnosis of the ’Red Eye’: a systematic review. Am J Med 2015;128:1220–1224.e1221.
7. Everitt H, Little P. How do GPs diagnose and manage acute infective conjunctivitis? A GP survey. Fam Pract 2002;19:658–660.
8. La Rosa M, Lionetti E, Reibaldi M, et al. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr 2013;39:18.
9. Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol 2011;11:477–482.
10. Bielory L, Frohman LP. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 1992;89:1–15.
11. Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am 2010;30:323–336.
12. Wilson-Holt N, Dart JK. Thiomersal keratoconjunctivitis, frequency, clinical spectrum and diagnosis. Eye 1989;3:581–587.
13. Soparkar CN, Wilhelmus KR, Koch DD, Wallace GW, Jones DB. Acute and chronic conjunctivitis due to overthe- counter ophthalmic decongestants. Arch Ophthalmol 1997;115:34–38.
14. van Ketel WG, Melzer-van Riemsdijk FA. Conjunctivitis due to soft lens solutions. Contact Dermatitis 1980;6:321–324.
15. Woodland RM, Darougar S, Thaker U, Cornell L, Siddique M, Wania J, et al. Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan. Trans Royal Soc Trop Med Hygiene 1992;86:317–320.
16. Bielory BP, O’Brien TP, Bielory L. Management of seasonal allergic conjunctivitis: guide to therapy. Acta Ophthalmologica 2012;90:399–407.
17. Rietveld RP, van Weert HC, ter Riet G, Bindels PJ. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. BMJ 2003;327:789.
18. Rietveld RP, ter Riet G, Bindels PJ, Sloos JH, van Weert HC. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ 2004;329:206–210.
19. Jefferis J, Perera R, Everitt H, van Weert H, Rietveld R, Glasziou P, et al. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen Pract 2011;61:e542–548.
20. van Weert HC, Tellegen E, Ter Riet G. A new diagnostic index for bacterial conjunctivitis in primary care. A rederivation study. Eur J Gen Pract 2014;20:202–208.
21. Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA 2013;310:1721–1729.
22. Drew RJ, Cole TS, Newman W. How to use… eye swabs. Arch Dis Child Educ Pract Ed 2015;100:155–161.
23. Wong VW, Lai TY, Chi SC, Lam DS. Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea 2011;30:995–1002.
24. Kam KY, Ong HS, Bunce C, Ogunbowale L, Verma S. Sensitivity and specificity of the AdenoPlus point-of-care system in detecting adenovirus in conjunctivitis patients at an ophthalmic emergency department: a diagnostic accuracy study. Br J Ophthalmol 2015;99:1186–1189.
25. Stenson S, Newman R, Fedukowicz H. Laboratory studies in acute conjunctivitis. Arch Ophthalmology 1982;100:1275–1277.
26. Fitch CP, Rapoza PA, Owens S, Murillo-Lopez F, Johnson RA, Quinn TC, et al. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology 1989;96:1215–1220.
27. Newman H, Gooding C. Viral ocular manifestations: a broad overview. Rev Med Virol 2013;23:281–294.
28. O’Brien TP, Jeng BH, McDonald M, Raizman MB. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin 2009;25:1953–1961.
29. Singh G, Zhou X, Lee JY, Yousuf MA, Ramke M, Ismail AM, et al. Recombination of the epsilon determinant and corneal tropism: human adenovirus species D types 15, 29, 56, and 69. Virology 2015;485:452–459.
30. Kuo IC. Adenoviral keratoconjunctivitis: diagnosis, management, and prevention. Curr Ophthalmol Rep 2019;7:118–127. 31. Li J, Lu X, Sun Y, Lin C, Li F, Yang Y, et al. A swimming pool-associated outbreak of pharyngoconjunctival fever caused by human adenovirus type 4 in Beijing, China. Int J Infect Dis 2018;75:89–91. 32. Harley D, Harrower B, Lyon M, Dick A. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Comm Dis Intell 2001;25:9–12. 33. Sinclair RG, Jones EL, Gerba CP. Viruses in recreational water-borne disease outbreaks: a review. J Appl Microbiol 2009;107:1769–1780. 34. Darougar S, Grey RH, Thaker U, McSwiggan DA. Clinical and epidemiological features of adenovirus keratoconjunctivitis in London. Br J Ophthalmol 1983;67:1– 7. 35. Jhanji V, Chan TC, Li EY, Agarwal K, Vajpayee RB. Adenoviral keratoconjunctivitis. Surv Ophthalmol 2015;60:435–443. 36. Chintakuntlawar AV, Chodosh J. Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis. Ocul Immunol Inflamm 2010;18:341– 345. 37. Chigbu DI, Labib BA. Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist 2018;11:981–993. 38. Richmond S, Burman R, Crosdale E, et al. A large outbreak of keratoconjunctivitis due to adenovirus type 8. The Journal of hygiene 1984;93:285-291. 39. Okumus S, Coskun E, Tatar MG, Kaydu E, Yayuspayi R, Comez A, et al. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis. BMC Ophthalmol 2012;12:42.
40. Ghanem RC, Vargas JF, Ghanem VC. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis. Cornea 2014;33:1210–1213.
41. Gallenga PE, Lobefalo L, Colangelo L, Della Loggia G, Orzalesi N, Velati P, et al. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: a multicenter double-blind phase III study. Ophthalmologica 1999;213:250–257.
42. Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci 2008;336:254–264.
43. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Can J Ophthalmol 2002;37:228–237; discussion 237.
44. Gordon YJ, Gordon RY, Romanowski E, Araullo-Cruz TP. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 1993;100:1835–1839; discussion 1839–1840.
45. Junk AK, Chen PP, Lin SC, Nouri-Mahdavi K, Radhakrishnan S, Singh K, et al. Disinfection of Tonometers: a report by the American Academy of Ophthalmology. Ophthalmology 2017;124:1867–1875.
46. Bremond-Gignac D, Mariani-Kurkdjian P, Beresniak A, El Fekih L, Bhagat Y, Pouliquen P, et al. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients. Pediatr Infect Dis J 2010;29:222–226.
47. Varu DM, Rhee MK, Akpek EK, Amescua G, Farid M, Garcia-Ferrer FJ, et al. Conjunctivitis preferred practice pattern®. Ophthalmology 2019;126:P94–P169.
48. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 1991;112:29s–33s.
49. Trinavarat A, Atchaneeyasakul LO. Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study. J Ocul Pharmacol Ther 2012;28:53–58.
50. Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, et al. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol 2017;95:e686–e692.
51. Holland EJ, Bartlett JD, Paterno MR, Usner DW, Comstock TL. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. Cornea 2008;27:50–55.
52. Belfort R, Jr., Gabriel L, Martins Bispo PJ, Muccioli C, Zacharias Serapicos PC, Clark L, et al. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis. Adv Ther 2012;29:416–426.
53. Clement C, Capriotti JA, Kumar M, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Investigative ophthalmology & visual science 2011;52:339-344.
54. Pinto RD, Lira RP, Abe RY, Fernandes Felix JP, Fernandes Pereira AV, Leite Arieta CE, et al. Dexamethasone/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res 2015;40:870–877.
55. Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R. Randomized, controlled, phase 2 trial of povidoneiodine/ dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol 2019;205:197.
56. Levinger E, Slomovic A, Sansanayudh W, Bahar I, Slomovic AR. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 2010;29:638–640.
57. Jeng BH, Holsclaw DS. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis. Cornea 2011;30:958–961.
58. Reinhard T, Godehardt E, Pfahl HG, Sundmacher R. [Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. a pilot study]. Ophthalmologe 2000;97:764– 768.
59. Hillenkamp J, Reinhard T, Ross RS, Böhringer D, Cartsburg O, Roggendorf M, et al. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Arch Ophthal 2001;119:1487–1491.
60. Berisa Prado S, Riestra Ayora AC, Lisa Fernandez C, Chacon Rodriguez M, Merayo-Lloves J, Alfonso Sanchez JF. Topical tacrolimus for corneal subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 2017;36:1102–1105.
61. Cronau H, Kankanala RR, Mauger T. Diagnosis and management of red eye in primary care. Am Fam Phys 2010;81:137–144.
62. Sheikh A, Hurwitz B, van Schayck CP, McLean S, Nurmatov U. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2012;19:Cd001211.
63. Papa V, Aragona P, Scuderi AC, Blanco AR, Zola P, Alessandro Di B, et al. Treatment of acute bacterial conjunctivitis with topical netilmicin. Cornea 2002;21:43– 47.
64. Puri LR, Shrestha GB, Shah DN, Chaudhary M, Thakur A. Ocular manifestations in herpes zoster ophthalmicus. Nepal J Ophthalmol 2011;3:165–171.
65. Sy A, McLeod SD, Cohen EJ, Margolis TP, Mannis MJ, Lietman TM, et al. Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea 2012;31:786–790.
66. Lim KH, Yin-Murphy M. Epidemic conjunctivitis in Singapore in 1970 and 1971. Singapore Med J 1973;14:86– 89.
67. Kono R, Sasagawa A, Miyamura K, Tajiri E. Serologic characterization and sero-epidemiologic studies on acute hemorrhagic conjunctivitis (AHC) virus. Am J Epidemiol 1975;101:444–457.
68. Zhang L, Zhao N, Huang X, Jin X, Geng X, Chan TC, et al. Molecular epidemiology of acute hemorrhagic conjunctivitis caused by coxsackie a type 24 variant in China, 2004-2014. Sci Rep 2017;7:45202.
69. Langford MP, Anders EA, Burch MA. Acute hemorrhagic conjunctivitis: anti-coxsackievirus A24 variant secretory immunoglobulin A in acute and convalescent tear. Clin Ophthalmol 2015;9:1665–1673.
70. Serin S, Bozkurt Oflaz A, Karabagli P, Gedik S, Bozkurt B. Eyelid molluscum contagiosum lesions in two patients with unilateral chronic conjunctivitis. Turk J Ophthalmol 2017;47:226–230.
71. Breman JG, Heymann DL, Lloyd G, McCormick JB, Miatudila M, Murphy FA, et al. Discovery and description of ebola zaire virus in 1976 and relevance to the West African epidemic during 2013-2016. J Infect Dis 2016;214:S93– S101.
72. Moshirfar M, Fenzl CR, Li Z. What we know about ocular manifestations of Ebola. Clin Ophthalmol 2014;8:2355– 2357.
73. Bausch DG, Schwarz L. Outbreak of ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis 2014;8:e3056–e3056.
74. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LYC, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-1325.
75. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:P497–P506.
76. Karimi S, Arabi A, Shahraki T, Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye. Retrieved from: https://doi.org/10.1038/s41433-020-0965-2.
77. Epling J. Bacterial conjunctivitis. BMJ Clin Evid 2012;2012:0704.
78. Shields T, Sloane PD. A comparison of eye problems in primary care and ophthalmology practices. Fam Med 1991;23:544–546.
79. Karpecki P, Depaolis M, Hunter JA, White EM, Rigel L, Brunner LS, et al. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehiclecontrolled, 5-day efficacy and safety study. Clin Ther 2009;31:514–526.
80. Hovding G. Acute bacterial conjunctivitis. Acta Ophthalmol 2008;86:5–17.
81. Horven I. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol. Acta Ophthalmol 1993;71:165–168.
82. Wall AR, Sinclair N, Adenis JP. Comparison of fucithalmic (fusidic acid viscous eyedrops 1%) and noroxin (norfloxacin ophthalmic solution 0.3%) in the treatment of acute bacterial conjunctivitis. J Drug Assess 1998;1:549–558.
83. Rose PW, Harnden A, Brueggemann AB, Perera R, Sheikh A, Crook D, et al. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet 2005;366:37–43.
84. Schiebel NE. Evidence-based emergency medicine/systematic review abstract. Use of antibiotics in patients with acute bacterial conjunctivitis. Ann Emer Med 2003;41:407–409.
85. Gong L, Sun XH, Qiu XD, Zhang Y-Q, Qu J, Yuan Zl, et al. [Comparative research of the efficacy of the gatifloxacin and levofloxacin for bacterial conjunctivitis in human eyes]. [Zhonghua yan ke za zhi] Chinese J Ophthalmol 2010;46:525–531.
86. Tepedino ME, Heller WH, Usner DW, Brunner LS, Morris TW, Haas W, et al. Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis. Curr Med Res Opin 2009;25:1159–1169.
87. Hwang DG, Schanzlin DJ, Rotberg MH, Foulks G, Raizman MB. A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Br J Ophthalmol 2003;87:1004– 1009.
88. Shanmuganathan VA, Armstrong M, Buller A, Tullo AB. External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA). Eye 2005;19:284–291.
89. Zhang M, Hu Y, Chen F. [Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis]. Yan Ke Xue Bao [Eye Sci] 2000;16:146–148.
90. Gross RD, Lichtenstein S, Schlech BA, Gower LA, Potts SL. Early clinical and microbiological responses in the treatment of bacterial conjunctivitis with moxifloxacin ophthalmic solution 0.5% (VigamoxTM ) using B.I.D. dosing. Today Ther Trends 2003;21:227–237.
91. Thareja T, Kowalski R, Jhanji V, Kamyar R, Dhaliwal D. MRSA keratitis and conjunctivitis: what does it mean practically? Curr Ophthalmol Rep 2019;7:110–117.
92. Burton MJ. Trachoma: an overview. Br Med Bull 2007;84:99–116.
93. Granet DB, Dorfman M, Stroman D, Cockrum P. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. J Pediatr Ophthalmol Strabismus 2008;45:340–349.
94. Leibowitz HM. The red eye. New Engl J Med 2000;343:345–351.
95. Tabbara KF, El-Sheikh HF, Islam SM, Hammouda E. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%. Eur J Ophthalmol 1999;9:269–275.
96. Abelson MB, Heller W, Shapiro AM, Si E, Hsu P, Bowman LM. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. Am J Ophthalmol 2008;145:959–965.
97. Cochereau I, Meddeb-Ouertani A, Khairallah M, Amraoui A, Zaghloul K, Pop M, et al. 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. Br J Ophthalmol 2007;91:465–469.
98. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis 2005;16:235–244.
99. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G. Neonatal conjunctivitis - a review. Malays Fam Phys 2008;3:77–81.
100. Castro Ochoa KJ, Mendez MD. Ophthalmia Neonatorum. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2020.
101. Forster RK, Dawson CR, Schachter J. Late follow-up of patients with neonatal inclusion conjunctivitis. Am J Ophthalmol 1970;69:467–472.
102. Tipple MA, Beem MO, Saxon EM. Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than 6 months of age. Pediatrics 1979;63:192–197.
103. Zikic A, Schunemann H, Wi T, Lincetto O, Broutet N, Santesso N. Treatment of neonatal chlamydial conjunctivitis: a systematic review and meta-analysis. J Pediatr Infect Dis Soc 2018;7:e107–e115.
104. Hammerschlag MR, Gelling M, Roblin PM, Kutlin A, Jule JE. Treatment of neonatal chlamydial conjunctivitis with azithromycin. Pediatr Infect Dis J 1998;17:1049–1050.
105. Srivastava K, Arora A, Kataria A, Cappelleri JC, Sadosky A, Peterson AM. Impact of reducing dosing frequency on adherence to oral therapies: a literature review and metaanalysis. Patient Prefer Adherence 2013;7:419–434.
106. Costumbrado J, Ng DK, Ghassemzadeh S. Gonococcal conjunctivitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
107. Hammerschlag MR, Smith-Norowitz T, Kohlhoff SA. Keeping an eye on Chlamydia and gonorrhea conjunctivitis in infants in the United States, 2010-2015. Sex Transm Dis 2017;44:577.
108. Pak KY, Kim SI, Lee JS. Neonatal bacterial conjunctivitis in Korea in the 21st century. Cornea 2017;36:415–418.
109. Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 2007;7:429–435.
110. Wong AH, Barg SS, Leung AK. Seasonal and perennial allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov 2014;8:139–153.
111. Bonini S. Atopic keratoconjunctivitis. Allergy 2004;59:71–73.
112. Rathi VM, Murthy SI. Allergic conjunctivitis. Commun Eye Health 2017;30:S7–S10.
113. Sofi RA, Mufti A. Vernal keratoconjunctivitis in Kashmir: a temperate zone. Int Ophthalmol 2016;36:875–879.
114. Katelaris CH. Ocular allergy in the Asia Pacific region. Asia Pac Allergy 2011;1:108–114.
115. De Smedt S, Wildner G, Kestelyn P. Vernal keratoconjunctivitis: an update. Br J Ophthalmol 2013;97:9–14.
116. Jun J, Bielory L, Raizman MB. Vernal conjunctivitis. Immunol Allergy Clin North Am 2008;28:59–82, vi.
117. Zicari AM, Capata G, Nebbioso M, De Castro G, Midulla F, Leonardi L, et al. Vernal keratoconjunctivitis: an update focused on clinical grading system. Ital J Pediatr 2019;45:64.
118. Zicari AM, Nebbioso M, Zicari A, Mari E, Celani C, Occasi F, et al. Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. Eur Rev Med Pharmacol Sci 2013;17:1242–1244.
119. Validad MH, Khazaei HA, Pishjoo M, Safdari Z. The study of Interleukin-17 level in vernal keratoconjunctivitis disease and its relationship between symptom and sign severity. Sem Ophthalmol 2017;32:721–724.
120. Occasi F, Zicari AM, Petrarca L, Nebbioso M, Salvatori G, Duse M. Vernal keratoconjunctivitis and immunemediated diseases: one unique way to symptom control? Pediatr Allergy Immunol 2015;26:289–291.
121. Zicari AM, Nebbioso M, Lollobrigida V, Bardanzellu F, Celani C, Occasi F, et al. Vernal keratoconjunctivitis: atopy and autoimmunity. Eur Rev Med Pharmacol Sci 2013;17:1419–1423.
122. Singhal D, Sahay P, Maharana PK, Raj N, Sharma N, Titiyal JS. Vernal keratoconjunctivitis. Surv Ophthalmol 2019;64:289–311.
123. Pucci N, Novembre E, Lombardi E, Cianferoni A, Bernardini R, Massai C, et al. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms. Clin Exp Allergy 2003;33:325–330.
124. Kumagai N, Fukuda K, Fujitsu Y, Yamamoto K, Nishida T. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res 2006;25:165–187.
125. Leonardi A, Bogacka E, Fauquert JL, Kowalski ML, Groblewska A, Jedrzejczak-Czechowicz M, et al. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy 2012;67:1327– 1337.
126. Solomon A. Corneal complications of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol 2015;15:489–494.
127. Cameron JA, Mullaney PB. Amblyopia resulting from shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. J Pediatr Ophthalmol Strabismus 1997;34:261–262.
128. Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology 1995;102:985–993.
129. Totan Y, Hepsen IF, Cekic O, Gunduz A, Aydin E. Incidence of keratoconus in subjects with vernal keratoconjunctivitis: a videokeratographic study. Ophthalmology 2001;108:824–827.
130. Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol 2010;10:478–485.
131. Offiah I, Calder VL. Immune mechanisms in allergic eye diseases: what is new? Curr Opin Allergy Clin Immunol 2009;9:477–481.
132. Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol 2014;70:569–575.
133. Li A, Li S, Ruan F, Jie Y. Atopic keratoconjunctivitis: a diagnostic dilemma-a case report. Medicine 2018;97:e0372.
134. Elhers WH, Donshik PC. Giant papillary conjunctivitis. Curr Opin Allergy Clin Immunol 2008;8:445–449.
135. Forister JF, Forister EF, Yeung KK, Ye P, Chung MY, Tsui A, et al. Prevalence of contact lens-related complications: UCLA contact lens study. Eye Contact Lens 2009;35:176– 180.
136. Vengayil S, Vanathi M, Dada T, Kai S, Panda A. Filtering bleb-induced giant papillary conjunctivitis. Cont Lens Anterior Eye 2008;31:41–43.
137. Elhers W, Donshik P. Giant papillary conjunctivitis. Curr Opin Allergy Clin Immunol 2008;8:445–449.
138. Donshik PC, Ehlers WH, Ballow M. Giant papillary conjunctivitis. Immunol Allergy Clin North Am 2008;28:83–103, vi.
139. Niederkorn JY. Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models. Curr Opin Allergy Clin Immunol 2008;8:472–476.
140. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008;57:121–134.
141. Dart J. Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease. Eye 2003;17:886–892.
142. Schmid KL, Schmid LM. Ocular allergy: causes and therapeutic options. Clin Exp Optom 2000;83:257–270.
143. Gokhale NS. Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm. Indian J Ophthalmol 2016;64:145–148.
144. Owen CG, Shah A, Henshaw K, Smeeth L, Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. Br J Gen Pract 2004;54:451–456.
145. Mishra GP, Tamboli V, Jwala J, Mitra AK. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov 2011;5:26–36.
146. Maziak W, Behrens T, Brasky TM, Duhme H, Rzehak P, Weiland SK, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Munster, Germany. Allergy 2003;58:572–579.
147. Welch D, Ousler GW, 3rd, Nally LA, Abelson MB, Wilcox KA. Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect. Adv Exp Med Biol 2002;506:1051–1055.
148. Broide DH. Immunomodulation of allergic disease. Ann Rev Med 2009;60:279–291.
149. Szamocki S, Martyn-Hemphill C, Green J. Reactive arthritis: can’t see, can’t pee, can’t climb a tree…. Trends Urol Men Health 2016;7:17–20.
150. Keat A. Reiter’s syndrome and reactive arthritis in perspective. New Engl J Med 1983;309:1606–1615.
151. Hamdulay SS, Glynne SJ, Keat A. When is arthritis reactive? Postgrad Med J 2006;82:446–453.
79
Krishna Kumar V, Azeem Ahmad, Alok Kumar Srivastava, Pallavi Namdev Kamble, D. Sudhakar, Pratap Makhija, Bhogavalli C. Rao, N. Srikanth (2022)
Efficacy and Safety of Ayurveda interventions in the management of conjunctivitis: A systematic review and meta-analysis, Complementary Therapies in Clinical PracticeVolume: 47, First Page: 101568
10.1016/j.ctcp.2022.101568
Jatinder Kaur, Anjali, Jasmeen Kaur, Pooja Rani, Poonam Mundlia, Suraj Pratap Singh, Rahul Shukla, Ashish Suttee, Ravi Pratap Barnwal, Gurpal Singh (2024)
Recent advances in nanomedicines for the treatment of global infectious diseases,First Page: 311
10.1016/B978-0-443-13337-4.00010-0
Isabella Wagner, Kannan Sharma, Cheryl Khanna, Michael Stewart, Adam Snowden, P Lentz, Yazan Abubaker, Pranav Vasu, Abhimanyu Ahuja, Richard Ten Hulzen, Syril Dorairaj, Darby Miller (2025)
Incidence of Conjunctivitis and Keratitis with Reusable Ophthalmic Laser Lenses at an Academic Medical Center, Clinical OphthalmologyVolume: Volume 19, First Page: 4169
10.2147/OPTH.S558732
Tara M. McSwigan, David Beck, Deborah Farkas (2022)
A rapid review of the red eye, JAAPAVolume: 35, Issue: 7, First Page: 40
10.1097/01.JAA.0000832600.20016.d9
Vivian Y. Shi, Winston Chamberlain, Elaine Siegfried, Cheryl Kraff-Cooper, Kenneth Beckman, Peter Lio, Amy S. Paller, Eric Simpson (2023)
Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review, Journal of the American Academy of DermatologyVolume: 89, Issue: 2, First Page: 309
10.1016/j.jaad.2023.01.043
Shahid Nawaz, Muhammad Zeeshan, Hasan Ayaz, Asim Iqbal, Farhad Ali, Asad Ali (2024)
The Outbreak of Highly Contagious Conjunctivitis (Pink Eye) in Major Cities of Pakistan, The Open Infectious Diseases JournalVolume: 16, Issue: 1
10.2174/0118742793285298240408052559
Manon Jammes, Abbas Tabasi, Trung Bach, Thomas Ritter (2025)
Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVs, Progress in Retinal and Eye ResearchVolume: 105, First Page: 101325
10.1016/j.preteyeres.2024.101325
Jong Yeon Lee, Gad Heilweil, Phuc Le, Sindhu Saraswathy, Young-Kwon Hong, Christopher A. Girkin, Alex S. Huang (2021)
Structural Confirmation of Lymphatic Outflow from Subconjunctival Blebs of Live Humans, Ophthalmology ScienceVolume: 1, Issue: 4, First Page: 100080
10.1016/j.xops.2021.100080
Zainab Adel Hashim, Suzan Kahatan M. Salih, Marwan Younis Abdulla (2024)
Ocular Findings and Blurring of Vision Associated with COVID-19 Virus during Pandemics in Iraq, The Open Ophthalmology JournalVolume: 18, Issue: 1
10.2174/0118743641277380231212063936
Iulian Catalin Bratu, Irina Ruxandra Strambu , Iulia Alecsandra Salcianu , Marius Vacaru Carnaru , Olimpia Dumitriu-Buzia , Nicolae Sarbu , Ion Ciuca , Alina Mihaela Calin , Norin Forna (2024)
INNOVATIONS IN THE TREATMENT OF PEDIATRIC CONJUNCTIVITIS: MODERN SOLUTIONS FOR SMALL PATIENTS, Romanian Journal of Oral RehabilitationVolume: 16, Issue: 2, First Page: 706
10.62610/RJOR.2024.2.16.65
M.E. Efendiyeva (2025)
TOXIC CONJUNCTIVIT (CLINICAL CASES), Azerbaijan Journal of OphthalmologyIssue: 2025/17/02/53, First Page: 47
10.71110/ajo791020251702534756
Julian Schwebler, Christina Fey, Daniel Kampik, Christian Lotz (2023)
Full thickness 3D in vitro conjunctiva model enables goblet cell differentiation, Scientific ReportsVolume: 13, Issue: 1
10.1038/s41598-023-38927-8
Kazunobu Asao, Noriyasu Hashida (2025)
Overview of Microorganisms: Bacterial Microbiome, Mycobiome, Virome Identified Using Next-Generation Sequencing, and Their Application to Ophthalmic Diseases, MicroorganismsVolume: 13, Issue: 6, First Page: 1300
10.3390/microorganisms13061300
Michele N. Pham, Ramsay L. Fuleihan, Kathleen E. Sullivan, Charlotte Cunningham-Rundles (2022)
Ocular Manifestations in Primary Immunodeficiency Disorders: A Report From the United States Immunodeficiency Network (USIDNET) Registry, The Journal of Allergy and Clinical Immunology: In PracticeVolume: 10, Issue: 7, First Page: 1788
10.1016/j.jaip.2022.03.028
Edmund Tsui, Ruti Sella, Vivien Tham, Alan W. Kong, Esmeralda McClean, Lee Goren, Irit Bahar, Nina Cherian, Joana Ramirez, Reginald E. Hughes, Joseph K. Privratsky, Tania Onclinx, Rachel Feit-Leichman, Angel Cheng, Iliana Molina, Phillip Kim, Carol Yu, Kevin Ruder, Alexander Tan, Cindi Chen, YuHeng Liu, Thomas Abraham, Armin Hinterwirth, Lina Zhong, Travis C. Porco, Thomas M. Lietman, Gerami D. Seitzman, Thuy Doan, Lalitha Prajna, N. Venkatesh Prajna, Ramesh Gunasekaran, Sankalp Singh Sharma, Vishnu Teja, Meenu Chaudhary, Sanjeeta Sitaula, Ali Sié, Boubacar Coulibaly, Mamadou Bountogo, Thanapong Somkijrungroj, Vannarut Satitpitakul, Huy Tran, Linh Hoàng Mai, Thảo Hạ Xuân, Yen Tran, Cristhian A. Urzua, Fabian Vega, Felipe Salgado, Loreto Cuitino, Fernando Pérez Pérez, Jaime Macías Martínez, Van Charles Lansingh, Sukhumal Thanapaisal, Wipada Laovirojjanakul, George McKie, Kenia Chavez, Travis Redd, Winston Chamberlain, Wiwan Sansanayudh, Abba Kaka Hajia Yakoura, Abdou Amza, Abdoul Salam Youssoufou Souley, Adam Nouhou Diori, Beido Nassirou, Boubacar Kadri, Boubacar Mariama, Cissé Mamadou Ibrahim, Lamine Aboubacar Roufaye, Ramatou Boulhassane, Saley Ali, Zakou Abdou, Clare Kelliher, Laura Green, Hon Shing Ong, Jod Mehta, Yu-Chi Liu, De-Kuang Hwang, Nai-Wen Fan, Hong Sheng Chiong, Javier Lacorzana, Maria Cabrera-Aguas, Stephanie Watson, Elodie Lebas, Emily Colby, Stephen McLeod, Kuniyoshi Kanai, Meredith Whiteside, Steven Yeh, Tolulope Fashina, James Chodosh, Bridgit Tarkap, Jambi N. Garap, Magdalene Mangot, Edwin Amel, Fasihah Taleo, Johnson Kasso, Kalbule Willie, Madopule Nanu, Prudence Rymill, Anthony W. Solomon (2023)
Pathogen Surveillance for Acute Infectious Conjunctivitis, JAMA OphthalmologyVolume: 141, Issue: 12, First Page: 1140
10.1001/jamaophthalmol.2023.4785
Salama A. Al Yabhouni, Mohammad Sayem Mozumder, Nurudeen Hassan, Abdel-Hamid I. Mourad, Tareq M.A Issa MD (2024)
Nanocarrier-Based, ocular drug delivery: Challenges, prospects, and the therapeutic landscape in the United Arab Emirates, International Journal of PharmaceuticsVolume: 667, First Page: 124899
10.1016/j.ijpharm.2024.124899
Kholoud Mohy, Mona Elhabak, Nermeen A. Elkasabgy, Rania Hassan Fahmy, Nihal Farid Younes (2026)
Bilosomes-mediated trans-ocular delivery of azelastine hydrochloride for the treatment of allergic conjunctivitis: In vitro, ex vivo and in vivo investigations, Journal of Drug Delivery Science and TechnologyVolume: 115, First Page: 107673
10.1016/j.jddst.2025.107673
Ryan S. Q. Geng, Jacqueline Slomovic, Adrienn N. Bourkas, Allan Slomovic, Ronald G. Sibbald (2024)
Ocular rosacea: The often‐overlooked component of rosacea, JEADV Clinical PracticeVolume: 3, Issue: 5, First Page: 1349
10.1002/jvc2.428
Shiv Mangal, Ebenezer Bonyah, Vijay Shankar Sharma, Y. Yuan (2024)
A novel fractional-order stochastic epidemic model to analyze the role of media awareness in the spread of conjunctivitis, Healthcare AnalyticsVolume: 5, First Page: 100302
10.1016/j.health.2024.100302
Lydia Vielmetti, Shayna Hibbs, Hawke Yoon (2025)
Neonatal Visual Impairment: Etiologies, Screening, and Management, NeoReviewsVolume: 26, Issue: 6, First Page: e391
10.1542/neo.26-6-023
Rajveer Bhaskar , Monika Ola , Vaishnavi Madwe, Rohini Tikhe , Arun Pawar , Shivani Khade , Sunil Shinde (2025)
Eye Drops to smart gels: The future of ocular drug delivery, Journal of Drug Delivery and TherapeuticsVolume: 15, Issue: 5, First Page: 181
10.22270/jddt.v15i5.7115
Krishna Koradia, Arjun Dedakia, Hiral Koradia (2025)
Development and in vitro-in vivo evaluation of ocular insert containing ketorolac tromethamine and moxifloxacin hydrochloride, Annales Pharmaceutiques FrançaisesVolume: 83, Issue: 1, First Page: 163
10.1016/j.pharma.2024.10.002
Milad Abbasi, Hossein Aghamollaei, Ahmad Vaez, Ali Mohammad Amani, Hesam Kamyab, Shreeshivadasan Chelliapan, Sajad Jamalpour, Renato Zambrano-Dávila (2025)
Bringing ophthalmology into the scientific world: Novel nanoparticle-based strategies for ocular drug delivery, The Ocular SurfaceVolume: 37, First Page: 140
10.1016/j.jtos.2025.03.004
Kali Weiss, Nash Whitaker (2023)
Bacterial conjunctivitis, Visual Journal of Emergency MedicineVolume: 32, First Page: 101724
10.1016/j.visj.2023.101724
Mitra Akbari (2023)
Topical interferon alpha-2b is a proper alternative for management of adenoviral keratitis: A case report, Journal of Advanced Pharmacy Education and ResearchVolume: 13, Issue: 2, First Page: 12
10.51847/bHZyx16R2Y
Adaeze Linda Onugwu, Ikechukwu Ikwuegbu, Chizoba Victor Ejiofor, Patrick Chinedu Nwosu, Linda Ifunanya Odo, Oluebubechukwu Praise Eze, Peace Ifeyinwa Agu, Obinna Kingsley Ugwu, Sabastine Obinna Onugwu, Paul Achile Akpa, Anthony Amaechi Attama (2025)
Nanoemulsions for the ocular delivery of anti-infectives: challenges, advances and prospects in treating infectious eye diseases, NanoscaleVolume: 17, Issue: 43, First Page: 24926
10.1039/D5NR03888J
Eider Arana, Ana Gonzalo, Noelia Andollo, Felipe Goñi-de-Cerio, Paloma Gómez-Fernández, Clarisa Salado, Gonzalo Hernández, Tatiana Suárez-Cortés (2024)
The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study, Scientific ReportsVolume: 14, Issue: 1
10.1038/s41598-024-59190-5
Sthita Pragnya Behera, Pooja Bhardwaj, Prashansha Srivastava, Shashikant Tiwari, Manoj Kumar, Nalini Mishra, Ritesh Kumar, Nirbhay Singh, Rajeev Singh, Hari Shanker Joshi, Gaurav Raj Dwivedi (2025)
A rare and first report of Ochrobactrum intermedium co-infection in coxsackievirus-A24-infected acute hemorrhagic conjunctivitis patients, Folia MicrobiologicaVolume: 70, Issue: 4, First Page: 891
10.1007/s12223-025-01300-5
Austin R. Swisher, Rijul S. Kshirsagar, Priscilla Q. Vu, Jonathan Liang (2024)
Ocular Surface Adverse Events are not Associated with Dupilumab use in Nasal Polyp Treatment, The LaryngoscopeVolume: 134, Issue: 6, First Page: 2602
10.1002/lary.31205
Qing Liu, Xiao-Jiao Tang, Xin-Ke Chen, Lin Chen (2024)
Flipped Classroom Based on Outcomes-Based Education Improves Student Engagement and Clinical Analysis Competence in Undergraduates Ophthalmology Clerkship, Advances in Medical Education and PracticeVolume: Volume 15, First Page: 599
10.2147/AMEP.S464898
Xuelin Tang, Jianhong Liu, Ruijiao Yan, Qiang Peng (2023)
Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review, International Journal of Biological MacromoleculesVolume: 242, First Page: 124902
10.1016/j.ijbiomac.2023.124902
Zeinab Mousavi, Masood Bagheri, Farid Najafi, Mahsa Yavari, Omid Bahiraee, Mehdi Moradinazar (2025)
Shedding light on pharmacoepidemiology of eye diseases: a cohort study in Western Iran, Scientific ReportsVolume: 15, Issue: 1
10.1038/s41598-025-09889-w
Roqia Bibi, Naveed Ahmed, Dildar Khan, Shahid Ali Khan, Adil Muhammad, Hadayat Ullah, Asim ur Rehman (2026)
NLCs based in situ gelling systems for ocular delivery of drug cargo against bacterial conjunctivitis, Journal of Drug Delivery Science and TechnologyVolume: 115, First Page: 107677
10.1016/j.jddst.2025.107677
A. V. Trubilin, E. G. Polunina, E. A. Serebryannikova, A. G. Iksanova, T. D. Ustinova (2025)
Efficacy and safety of ciprofloxacin, eye ointment and eye drops, 0.3 %, in modern therapy of infectious and inflammatory eye diseases. A review, Russian Ophthalmological JournalVolume: 18, Issue: 2, First Page: 160
10.21516/2072-0076-2025-18-2-160-167
Denis O. Shatalov, Diana A. Akhmedova, Ivan S. Ivanov, Daria D. Kirillova, Yulia A. Koroleva, Dmitry S. Minenkov, Stanislav A. Kedik (2024)
Application of a mixed type of optimization in the implementation of pharmaceutical development of a dosage form of eye drops based on oligohexamethyleneguanidine hydrosuccinate, Bulletin of the Russian Military Medical AcademyVolume: 26, Issue: 1, First Page: 35
10.17816/brmma625402
I. V. Vorobyeva, M. A. Frolov, Yu. B. Slonimskiy (2021)
Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases, Ophthalmology in RussiaVolume: 18, Issue: 3, First Page: 566
10.18008/1816-5095-2021-3-566-577
Sadiq Shaikh, Hassaam S. Choudhry, Hamza Khan, Riya Patel, David Mothy, Mohammad H. Dastjerdi (2025)
A Comprehensive Review of Adenoviral Conjunctivitis: Exploring the Role of Povidone-iodine in Treatment, International Ophthalmology ClinicsVolume: 65, Issue: 2, First Page: 1
10.1097/IIO.0000000000000556
Isabella Mei Yan Cheung, Tary Yin, Akilesh Gokul (2025)
Paediatric Utilisation of Ophthalmic Antibiotics in the Ear in Aotearoa/New Zealand, ChildrenVolume: 12, Issue: 5, First Page: 557
10.3390/children12050557
Luksanaporn Krungkraipetch, Taweelarp Tansavadi, Dechathorn Krungkraipetch (2025)
Ranking the efficacy of topical treatments for ocular allergy: A network meta-analysis of current evidence, The Ocular SurfaceVolume: 37, First Page: 273
10.1016/j.jtos.2025.05.003
Syed Sofiya Ali, Suman Kumar Swarnkar (2025)
Investigating vision transformers for imbalanced ocular image classification with explainable ai, Cuestiones de FisioterapiaVolume: 54, Issue: 5, First Page: 1112
10.48047/2mq0qf97
A. Yu. Malygin, A. B. Lisitsyn, O. M. Selina (2025)
Comparison of the Efficacy of Moxifloxacin Preparations in the Therapy of Conjunctivitis, Ophthalmology in RussiaVolume: 22, Issue: 2, First Page: 458
10.18008/1816-5095-2025-2-458-464
Sarah Barbara Zwingelberg (2025)
Konjunktivitis – Differenzialdiagnose und Therapie,First Page: 1451
10.1007/978-3-662-65823-9_141
Seunghwan Choy, Jin Mi Chun, Ji-Woo Seok, Se-Ra Park, Jung-Dae Kim (2025)
Effectiveness of photobiomodulation therapy for ophthalmic diseases: protocol for a systematic review and meta-analysis of disease-specific and shared physiological outcomes, Systematic ReviewsVolume: 14, Issue: 1
10.1186/s13643-025-02972-3
Maheshver Shunmugam, Francesca Giovannetti, Sonia N. Yeung, Alfonso Iovieno (2025)
An Update on Viral Conjunctivitis Treatment Strategies: A Narrative Literature Review, MicroorganismsVolume: 13, Issue: 8, First Page: 1712
10.3390/microorganisms13081712
Faustina Pappoe, Samuel Victor Nuvor (2021)
Host-Microbial Relationship: Immune Response to Microbial Infections with or without Medication,
10.5772/intechopen.97814
Richard C. Cabot, Eric S. Rosenberg, David M. Dudzinski, Meridale V. Baggett, Kathy M. Tran, Dennis C. Sgroi, Jo-Anne O. Shepard, Emily K. McDonald, Tara Corpuz, Miriam B. Barshak, Caitlin M. Dugdale, Roberto Pineda (2023)
Case 14-2023: A 31-Year-Old Man with Redness of the Right Eye, New England Journal of MedicineVolume: 388, Issue: 19, First Page: 1800
10.1056/NEJMcpc2211511
Sarah Barbara Zwingelberg (2024)
Konjunktivitis – Differenzialdiagnose und Therapie,First Page: 1
10.1007/978-3-662-65929-8_141-1
Naureen Afrose, Rideb Chakraborty, Pratibha Bhowmick, Mithun Bhowmick (2025)
Validation in Sterile Ophthalmic Formulation,First Page: 333
10.1007/978-981-96-6306-4_11
Shilpa Goyal (2025)
Hemostasis,First Page: 25
10.1007/978-981-96-8614-8_3
Sazan Q. Maulud, Lawin A. Omar, Ahmed Nawzad Hassan, Rastee H. Saeed (2020)
Microbial and Molecular Screening of Swimmers Associated with Conjunctivitis from Public Swimming Pools in Erbil Province, Al-Mustansiriyah Journal of ScienceVolume: 31, Issue: 4, First Page: 36
10.23851/mjs.v31i4.903
Sourav Mohanto, J.C. Darshan, Abdul Mannan Faruk Ahmed, Prolay Paul, Adrija Bhunia, Tanvi Goel, Sagnik Nag, Amol Dilip Gholap, Mohammed Gulzar Ahmed (2025)
Cost, Benefits, and Side Effects of Allopathic Medicine to Control Communicable Diseases,First Page: 261
10.1002/9781394204595.ch10
Satish Patel, Dharmendra Baria (2023)
Validated thin‐layer chromatography method for simultaneous determination of sulfacetamide sodium and hydrocortisone acetate in the ophthalmic formulation, SEPARATION SCIENCE PLUSVolume: 6, Issue: 2
10.1002/sscp.202200090
Thresia Sebastian, Holly M. Frost (2022)
A qualitative evaluation of pediatric conjunctivitis medical decision making and opportunities to improve care, Journal of American Association for Pediatric Ophthalmology and StrabismusVolume: 26, Issue: 3, First Page: 113.e1
10.1016/j.jaapos.2021.12.008
Afewerki Tesfahunegn Nigusse, Kissanet Tesfay Weldearegay, Haftamu Assefa Mezgebu, Yohannes Gebrehawarya Bisheu, Letebrhan Weldemhret Teweldemedhnt, Mebrahtom Hafte Amaha, Migbnesh Gebremedhin Weledegebriel, Rieye Esayas Belay (2024)
Conjunctivitis outbreak among children in Central zone of Tigray, Northern Ethiopia 2023, Journal of Interventional Epidemiology and Public HealthVolume: 7, Issue: 4
10.37432/jieph.2024.7.4.143
Helena Siegel, Stefan Lang, Philip Maier, Thomas Reinhard (2023)
Bakterielle Konjunktivitis: Aktuelle Aspekte der Diagnostik und Therapie, Augenheilkunde up2dateVolume: 13, Issue: 04, First Page: 281
10.1055/a-2104-9622
S Mohan, Santosh Kumar, G Pawan Kumar, Anjali Maheswari, Agrima Bhatia, Anand Sagar (2023)
Assessment of the efficacy of olopatadine 0.1% in the treatment of vernal keratoconjunctivitis in terms of clinical improvement based on total ocular symptom score and ocular surface disease index, Indian Journal of OphthalmologyVolume: 71, Issue: 5, First Page: 1822
10.4103/ijo.IJO_2048_22
Luis Fernando Valladales-Restrepo, Manuel Enrique Machado-Duque, Andrés Gaviria-Mendoza, Diana Fiorella López-Caicedo, Juan Alberto Ospina-Cano, María Camila Oyuela-Gutiérrez, Dayron Fernando Martínez-Pulgarín, Jorge Enrique Machado-Alba (2022)
Indication-prescription study for the management of conjunctivitis in a Colombian population, International OphthalmologyVolume: 43, Issue: 1, First Page: 83
10.1007/s10792-022-02390-7
Kenneth McNair Gilmour, Kanna Ramaesh (2023)
Case for conservative management of adenoviral pseudomembranous conjunctivitis, BMJ Case ReportsVolume: 16, Issue: 2, First Page: e253014
10.1136/bcr-2022-253014
Arezoo Rajaee, Meghane E. Masquelin, Katherine M. Pohlgeers (2021)
Pediatric Allergy, Primary Care: Clinics in Office PracticeVolume: 48, Issue: 3, First Page: 517
10.1016/j.pop.2021.04.006
Soumya Jindal, Palak Handa, Nidhi Goel (2024)
OphthaPredict: Automatic Classification of Conjunctivitis Using Deep Learning Architecture,Volume: 891, First Page: 457
10.1007/978-981-99-9524-0_35
Susan J. Ching, Ga On Jung, Angela Osuna, Theresa Casey, Hui Xia, Karina Bostwick, Amol H. Patadia, Lauren M. Sweet, Oscar Gallardo-Huizar, Thomas F. Gibbons, Joseph E. Marcus (2025)
Outbreak of Neisseria meningitidis Conjunctivitis in Military Trainees — Texas, February–May 2025, MMWR. Morbidity and Mortality Weekly ReportVolume: 74, Issue: 33, First Page: 516
10.15585/mmwr.mm7433a1
Jalindar Gandal, Walid Ayadi, Yasser Farhat, P.S. Metkewar, Showkat A. Bhat, Aafaq A. Rather (2025)
A Novel Method for Viral Conjunctivitis Detection using CNN-Based Image Analysis, International Journal of Statistics in Medical ResearchVolume: 14, First Page: 601
10.6000/1929-6029.2025.14.57
Shuangqing Chang, Qinghua Luo, Zhifang Huang (2024)
Genetic association and causal effects between inflammatory bowel disease and conjunctivitis, Frontiers in ImmunologyVolume: 15
10.3389/fimmu.2024.1409146
Chintan Shah, Courtney F. Goodman, Alok Sen, Deepak P. Edward, Manish Tijare (2025)
Comparison of Tobramycin-Dexamethasone Combination Eyedrop Versus Artificial Tear Eyedrop for the Management of Presumed Viral Epidemic Conjunctivitis: A Randomized Treatment Trial, Current Eye ResearchVolume: 50, Issue: 10, First Page: 994
10.1080/02713683.2025.2515997
Xiaohan Kong, Yizhen Jia, Han Wang, Rui Li, Chujie Li, Shihong Cheng, Tian Chen, Yang Mai, Yichu Nie, Yang Deng, Zhiyong Xie, Yang Liu (2023)
Effective Treatment of Haemophilus influenzae-Induced Bacterial Conjunctivitis by a Bioadhesive Nanoparticle Reticulate Structure, ACS Applied Materials & InterfacesVolume: 15, Issue: 19, First Page: 22892
10.1021/acsami.3c01308
Henry Kissinger Ansong, Divya Nair, Joana Abokoma Koomson, Obed Kwabena Offe Amponsah, Jane Frances Acquah, James Buckman, Andrew Ramsay, Paa Kwesi Fynn Hope (2025)
Improved Antibiotic Prescribing for Acute Conjunctivitis After Operational Research: A Before-and-After Study in a Ghanaian Eye Hospital, Tropical Medicine and Infectious DiseaseVolume: 10, Issue: 11, First Page: 301
10.3390/tropicalmed10110301
Penny A. Asbell, Christine M. Sanfilippo, Heleen H. DeCory (2024)
Antibiotic resistance of bacterial pathogens isolated from the conjunctiva in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance study (2009–2021), Diagnostic Microbiology and Infectious DiseaseVolume: 108, Issue: 1, First Page: 116069
10.1016/j.diagmicrobio.2023.116069
S. Madhusudhan, S. Anitha (2025)
Validating Color Models for Preprocessing Retinal Color Fundus Images in Automatic Detection of Cotton Wool Spot and Conjunctiva Abnormalities,Volume: 1293, First Page: 153
10.1007/978-981-96-3247-3_13
Fabio Urbina, Scott H. Greenwald, Patricia A. Vignaux, Thomas R. Lane, Joshua S. Harris, Mayssa Attar, Keith Luhrs, Sean Ekins (2025)
MegaEye: Applying multiple machine learning approaches to identify oral compounds with ocular bioactivity, Artificial Intelligence in the Life SciencesVolume: 8, First Page: 100143
10.1016/j.ailsci.2025.100143
Helena Siegel, Stefan Lang, Philip Maier, Thomas Reinhard (2024)
Bakterielle Konjunktivitis: Aktuelle Aspekte der Diagnostik und Therapie, Klinische Monatsblätter für AugenheilkundeVolume: 241, Issue: 02, First Page: 231
10.1055/a-2193-2658
Kari N. Schweiger (2025)
Eye and Ear Complaints,First Page: 243
10.1007/978-3-031-85765-2_31
B. H. Jaswanth Gowda, Lalitkumar K. Vora, Shilpkala Gade, Katie Glover, Mohammed Gulzar Ahmed, Raghu Raj Singh Thakur (2024)
Therapeutic Applications of Nanobiomaterials for the Management of Ocular Diseases,First Page: 329
10.1007/978-981-97-3925-7_12
Jong Yeon Lee, Clemens Adolf Strohmaier, Goichi Akiyama, Sindhu Saraswathy, Chungkwon Yoo, Yong Yeon Kim, Young-Kwon Hong, Alex S Huang (2023)
Bleb-related Porcine Lymphatic Outflow Is Greater from Subconjunctival compared to Subtenon Blebs, Journal of Current Glaucoma PracticeVolume: 16, Issue: 3, First Page: 144
10.5005/jp-journals-10078-1382
Adem SOYDAN, Abdulgani KAYMAZ, Erol AYAZ, Kerem YAMAN, Mücahit ÇAKMAK, Abdullah BAYRAK, Metin OKŞAR (2023)
Investigation of the Relationship Between Chronic Use of Topical Antiglaucomatous Drops and Ocular Demodex Infestation, Journal of Contemporary MedicineVolume: 13, Issue: 2, First Page: 225
10.16899/jcm.1233866
Jyothi N. Sanganal, Asharani Shinde, MD Iqbal Ahmed, Sakib Akther Pattassery, Susha Subash, Srinivas Vilasagaram, Praveen Kumar, Marappa Narayana, Ashok Munivenkatappa (2025)
Molecular analysis of acute hemorrhagic conjunctivitis in a tertiary care hospital, Kalburgi district, Karnataka 2023, Indian Journal of Medical MicrobiologyVolume: 53, First Page: 100785
10.1016/j.ijmmb.2024.100785
Anil Kilinc, Nilay Tas, Melih Urkmez, Ebru Canakci, Ilker Coskun, Merve Elif Demirhan (2025)
Effects of Prognostic Nutrition Index, Neutrophil/Lymphocyte Ratio, and C-reactive Protein/Albumin Ratio on Prognosis Undergoing Open Heart Surgery, Medical Bulletin of HasekiVolume: 62, Issue: 5, First Page: 295
10.4274/haseki.galenos.2024.9873
Nimeet Desai, Helen E. Colley, Yamini Krishna, Lucy A. Bosworth, Victoria R. Kearns (2025)
Mucoadhesive nanofibers for ocular drug delivery: mechanisms, design strategies, and applications, Drug Delivery and Translational Research
10.1007/s13346-025-01894-w
Lakshi M. Aldredge, Winston D. Chamberlain, Vivian Y. Shi (2024)
Podcast on Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases, Dermatology and TherapyVolume: 14, Issue: 2, First Page: 293
10.1007/s13555-023-01093-w
